Tuesday, February 23, 2021 9:38:28 AM
The verbiage actually skirts the "ownership" of ITV-1(ImmunH).
Every reference to the "patent" of ITV-1 has/or is tagged with another part of the "compound or as an association as a compound".
In the bottom of the article when they talk about Enzolytics history, "compound ITV-1 (Immune Therapeutic Vaccine-1)" is a reference to his patent under ENZC as a "compound" not the actual ImmunH as a standalone patented material under ENZC.
I have emailed IMMB to see if they can clear up the ownership of the patent, but I don't think it's necessary for that confirmation.
It's pretty clear that the wording had to be digested a bit more than originally thought.
My claim, IMMB holds the patent to ImmunH(ITV-1).
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM